Stock info Bactiguard | Filter  Basic-Info

Bactiguard

The past year was a profitable year Bactiguard investors

Over the last 12 months, that were profitable period for the investors in Bactiguard, the stock gained around 49 percent. Over the past 5 years Bactiguard' stock lost at around 0 percent in value. Bactiguard's revenues between 2011 and 2015 were relatively stable and moved between 131,82 million SEK and 138,46 million SEK.

Bactiguard has located her head office Stockholm. The global health care companies gained over the past 10 years on average 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.

The Swedish company didn't pay out any dividends (in the past 5 years).

The Swedish company had ultimo 2015 approximately 8481 thousand employees on it's payroll.

Bactiguard' balance mostly financed with equity

At the end of 2015 the health care company's balance sheet was worth 676,25 million SEK. Of the total balance sheet 676,25 million SEK (100 percent) was financed by debt. As per the end of 2015 Bactiguard's price/earnings-ratio equaled -22. So investors paid for 1 stock -22 times the earnings per share of 2015. Based on the classical stock valuation theories the Swedish stock can be seen as a value stock.

At the end of 2015 the Swedish company's market capitalization equaled around 502,87 million SEK. At the end of 2015 the Swedish company had around 33,3 million stocks listed on the stock exchange(s).

All Bactiguard's annual reports can be found here. More information about Bactiguard can be found it's website. .